Clinical Trials Directory

Trials / Completed

CompletedNCT02188251

A Study Investigating the Effects of Activamp on Body Weight, Fat Loss, and Metabolic Markers in Healthy Overweight Participants

A Randomized, Double-blind, Placebo Controlled, Parallel Study Investigating the Effects of Activamp on Body Weight, Fat Loss, and Metabolic Markers in Healthy Overweight Participants

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
100 (actual)
Sponsor
KGK Science Inc. · Industry
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the effects of Activamp, a product containing gynostemma pentaphyllum extract, on body weight, fat loss and metabolic markers in healthy overweight adults.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTActivamp
OTHERPlacebo

Timeline

Start date
2014-09-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2014-07-11
Last updated
2015-08-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02188251. Inclusion in this directory is not an endorsement.